NYSEMKT:MYO

Myomo Stock Insider Trading

Healthcare > Medical - Devices

Buy MYO

*Your capital is at risk

$1.00

+0.0699 (+7.52%)

At Close: Jul 30, 2026

Myomo Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 28.87. In total, the insiders bought 2.66M and sold 654.79K MYO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	28.87
● Buy	2.66M shares
● Sell	654.79K shares
69% Buy Activity Strong Negative Correlation
Buy Signal Medium Confidence Jun 25, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 28.87. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 15, 2025 Buy	Common Stock P-Purchase	Kirk Thomas F Director	Director	36 824 Value: $119.7K
May 14, 2025 Sell	Common Stock S-Sale	Mitchell Micah Chief Commercial Officer	Officer	90 231 Value: $77.7K
May 14, 2025 Buy	Common Stock P-Purchase	Kirk Thomas F Director	Director	1 943 Value: $6K
May 14, 2025 Buy	Common Stock P-Purchase	Kirk Thomas F Director	Director	1 943 Value: $6K
May 12, 2025 Buy	Common Stock P-Purchase	Kirk Thomas F Director	Director	50 000 Value: $167.5K
May 12, 2025 Buy	Common Stock P-Purchase	Kirk Thomas F Director	Director	50 000 Value: $167.5K
Mar 14, 2025 Sell	Common Stock S-Sale	Mitchell Micah Chief Commercial Officer	Officer	48 000 Value: $247.6K
Mar 14, 2025 Sell	Common Stock S-Sale	Mitchell Micah Chief Commercial Officer	Officer	48 000 Value: $247.6K
Mar 14, 2025 Sell	Common Stock S-Sale	Mitchell Micah Chief Commercial Officer	Officer	48 000 Value: $247.6K
Mar 14, 2025 Sell	Common Stock S-Sale	Mitchell Micah Chief Commercial Officer	Officer	48 000 Value: $247.6K
Mar 13, 2025 Buy	Common Stock P-Purchase	Kirk Thomas F Director	Director	7 400 Value: $37.0K
Mar 13, 2025 Buy	Common Stock P-Purchase	Kirk Thomas F Director	Director	7 400 Value: $37.0K
Mar 13, 2025 Sell	Common Stock F-InKind	Kovelman Harry Chief Medical Officer	Officer	1 496 Value: $8K
Mar 13, 2025 Sell	Common Stock F-InKind	Henry David A Chief Financial Officer	C-Suite Officer	2 019 Value: $10.5K
Mar 13, 2025 Sell	Common Stock F-InKind	Kovelman Harry Chief Medical Officer	Officer	1 496 Value: $8K
Mar 12, 2025 Sell	Common Stock S-Sale	Kovelman Harry Chief Medical Officer	Officer	30 000 Value: $165.0K
Mar 12, 2025 Sell	Common Stock S-Sale	Kovelman Harry Chief Medical Officer	Officer	30 000 Value: $165.0K
Mar 11, 2025 Buy	Common Stock A-Award	Mitchell Micah Chief Commercial Officer	Officer	3 737 Value: $21.9K
Mar 11, 2025 Buy	Common Stock A-Award	Mitchell Micah Chief Commercial Officer	Officer	3 737 Value: $21.9K
Mar 11, 2025 Buy	Common Stock A-Award	Kovelman Harry Chief Medical Officer	Officer	3 553 Value: $20.9K
Mar 11, 2025 Buy	Common Stock A-Award	Gudonis Paul R Chief Executive Officer	CEO / President	6 708 Value: $39.4K
Mar 11, 2025 Buy	Common Stock A-Award	Henry David A Chief Financial Officer	C-Suite Officer	4 106 Value: $24.1K
Mar 11, 2025 Buy	Common Stock A-Award	Henry David A Chief Financial Officer	C-Suite Officer	4 106 Value: $24.1K
Mar 11, 2025 Buy	Common Stock A-Award	Gudonis Paul R Chief Executive Officer	CEO / President	6 708 Value: $39.4K
Mar 11, 2024 Buy	Common Stock A-Award	Mitchell Micah Chief Commercial Officer	Officer	3 737 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MYOMO, INC

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents wit...

Read Full Profile Here